HIF1A and glioblastoma: In the present study, we report a HIF1α-dependent regulatory mechanism in GBM cells through which hypoxia can reversibly regulate the expression of the Trp-degrading enzyme TDO2 and thus the production of known immunosuppressive onco-metabolites.